3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Glioblastoma
49
Breast Neoplasms
49
Prostatic Neoplasms
47
Carcinoma, Non-Small-Cell Lung
47
Squamous Cell Carcinoma of Head and Neck
37
Lung Neoplasms
29
Head and Neck Neoplasms
26
Glioma
22
Rectal Neoplasms
21
Sarcoma
20
Neoplasms
20
Brain Neoplasms
20
Oropharyngeal Neoplasms
16
Esophageal Neoplasms
15
Uterine Cervical Neoplasms
14
Neoplasm Metastasis
14
Astrocytoma
13
Triple Negative Breast Neoplasms
12
Esophageal Squamous Cell Carcinoma
12
Carcinoma, Hepatocellular
12
Pancreatic Neoplasms
11
Melanoma
11
Gliosarcoma
10
Colorectal Neoplasms
10
Stomach Neoplasms
9
Small Cell Lung Carcinoma
9
Lymphoma
9
Hodgkin Disease
9
Carcinoma, Squamous Cell
9
Urinary Bladder Neoplasms
8
Interventions
atezolizumab
2
Carboplatin
2
durvalumab
1
anlotinib
1
Radiotherapy
1
Paclitaxel
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Etoposide
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Cancer Extensive Stage
×
Radiotherapy
×
1 year
×
Clear all
NCT06610734
2026-02-09
SKY
Sichuan University
Phase 2
Recruiting
202 enrolled